| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/06/2006 | US20060148082 Method for delivering a biological compound using neural progenitor cells derived from whole bone marrow |
| 07/06/2006 | US20060148030 Nuclear receptor err y 3 |
| 07/06/2006 | US20060148011 Diagnosing prostate cancer by contacting a biological fluid sample (plasma) or prostatic tissue specimen from the subject with an antibody which binds to SEQ ID NO: 1, detecting binding of the antibody in the specimen and correlating the detected binding to prostate cancer |
| 07/06/2006 | US20060148002 Methods and compositions for the treatment and diagnosis of body weight disorders |
| 07/06/2006 | US20060148001 Compositions and methods for treating female fertility |
| 07/06/2006 | US20060147988 Vertebrate transmembrane protein (UNC-5 protein) for use in diagnosis, prevention and treatment of nervous system disorders |
| 07/06/2006 | US20060147973 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01 |
| 07/06/2006 | US20060147952 2'-O-methyl-phosphorothioate oligoribonucleotide modification; peptide nucleic acids, locked nucleic acids, and/or morpholino phosphorodiamidate oligonucleotides; splicing to skip hybridization |
| 07/06/2006 | US20060147904 Use of resveratrol to regulate expression of apolipoprotein A1 |
| 07/06/2006 | US20060147525 Lipophilic drug compositions |
| 07/06/2006 | US20060147514 Method for introducing antisense oligonucleotides into eucaryotic cells |
| 07/06/2006 | US20060147513 Methods of forming targeted liposomes loaded with a therapeutic agent |
| 07/06/2006 | US20060147477 Immunogenic compositions |
| 07/06/2006 | US20060147456 Induction of apoptosis in toll-like receptor expressing tumor cells |
| 07/06/2006 | US20060147455 Gastric and colon cancer-associated antigens |
| 07/06/2006 | US20060147437 Use of pigmented retinal epithelial cells for creation of an immune privilege site |
| 07/06/2006 | US20060147436 interferon type 1 receptor 1 (IFNAR1)-binding proteins, used to enhanced the exogenous therapy or treatment of cancer |
| 07/06/2006 | US20060147435 Using glycogen synthase kinase-3 (GSK-3) inhibitors to increase endogenous hematopoietic adult stem cell or progenitor cell population in mammals for treatment of immune related, mesenchymal/mesoderm degenerative and/or neurodegenerative diseases |
| 07/06/2006 | US20060147434 Different dendritic cell subsets |
| 07/06/2006 | US20060147432 Tolerogenic antigen-presenting cells |
| 07/06/2006 | US20060147428 Allogeneic and xenogeneic transplantation |
| 07/06/2006 | US20060147422 Selective induction of apoptosis to treat ocular disease |
| 07/06/2006 | US20060147421 Methods and compositions for treating and preventing infection using human interferon regulatory factor 3 |
| 07/06/2006 | US20060147420 Oncolytic adenovirus armed with therapeutic genes |
| 07/06/2006 | US20060147419 Recombinant vaccine viruses expressing il-15 and methods of using the same |
| 07/06/2006 | US20060147418 Recombinant double stranded rna phages and uses thereof |
| 07/06/2006 | US20060147376 Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier |
| 07/06/2006 | CA2594245A1 Retrotransposon inhibition in therapy |
| 07/06/2006 | CA2593035A1 Pharmaceutical compositions for treating diseases associated with nf-.kappa.b activity |
| 07/06/2006 | CA2592699A1 Method for reversing multiple resistance in animal cells |
| 07/06/2006 | CA2592648A1 Methods and compositions for treating epithelial cancers |
| 07/06/2006 | CA2592461A1 Drugs for diseases accompanying changes in total bile acid pool or lipid metabolism disorders and method of screening these drugs |
| 07/06/2006 | CA2591403A1 Rnai inhibition of serum amyloid a for treatment of glaucoma |
| 07/05/2006 | EP1677113A1 Method for the identification of protein-protein interactions in disease related protein networks |
| 07/05/2006 | EP1676920A2 Anticoagulant fusion protein anchored to cell membrane |
| 07/05/2006 | EP1676918A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 07/05/2006 | EP1676917A2 Novel human kinases and uses thereof |
| 07/05/2006 | EP1676590A1 Oncogene therapeutic drug |
| 07/05/2006 | EP1676589A1 Oncogene therapeutic drug |
| 07/05/2006 | EP1675596A2 Method |
| 07/05/2006 | EP1675571A2 Nanoparticulate therapeutic biologically active agents |
| 07/05/2006 | EP1313762B1 Suppressor gene |
| 07/05/2006 | EP1274853B1 Materials and methods relating to immune responses to fusion proteins |
| 07/05/2006 | EP1235900B1 Microparticle-based transfection and activation of dendritic cells |
| 07/05/2006 | EP1196559B1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
| 07/05/2006 | EP1141318B1 P450 / acetaminophen gdept for cancer treatment |
| 07/05/2006 | EP0923740B1 Methods and compositions for the detection of cervical cancer |
| 07/05/2006 | EP0879289B1 Human dnase resistant to actin inhibition |
| 07/05/2006 | EP0778889B1 Recombinant adenovirus comprising a chimeric penton base protein |
| 07/05/2006 | EP0695360B1 Defective recombinant adenoviruses for gene therapy of tumours |
| 07/05/2006 | CN1798840A NOGO receptor binding protein. |
| 07/05/2006 | CN1798764A Peptide inhibitors of toxins derived from ll-37 |
| 07/05/2006 | CN1798579A Targets for tumor growth inhibition |
| 07/05/2006 | CN1798563A Immunostimulant |
| 07/05/2006 | CN1798545A Method for improving stability and shelf-life of liposome complexes |
| 07/05/2006 | CN1798502A Method for the treatment of malignancies |
| 07/05/2006 | CN1796567A Application of Nano carbon tubes in biology |
| 07/05/2006 | CN1796557A Structure and application of antisense oligonucleotide with gene of mid-range factor as target |
| 07/05/2006 | CN1796556A Control of gene expression |
| 07/05/2006 | CN1796555A Small interference RNA molecule for restraining protein expression of DNA-PKCS, and encoding gene and application |
| 07/05/2006 | CN1796411A New protein DDIP and coding genes and application |
| 07/05/2006 | CN1796404A Neisserial antigenic peptides |
| 07/05/2006 | CN1795928A Correlation factor of blastocyst nidation and application |
| 07/05/2006 | CN1262668C Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| 07/05/2006 | CN1262665C Code-optimized papilloma virus sequences |
| 07/05/2006 | CN1262664C Recombined procine adenovirus based on viral vaccines and vectors |
| 07/05/2006 | CN1262311C Medicinal composition for target direction transport curing cancer and its usage |
| 07/04/2006 | US7071321 Identifying a BASB033 polypeptide or an antibody that is immunospecific for such polypeptide, present with in a biological sample form the animal suspected having meningococcus induced infections and meningitis |
| 07/04/2006 | US7071317 Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods |
| 07/04/2006 | US7071316 Human Akt-3 |
| 07/04/2006 | US7071312 Epidermal differentiation factor |
| 07/04/2006 | US7071306 AMPA-binding human GluR4 receptors |
| 07/04/2006 | US7071301 Supplying vector; amino acid sequence for binding virus; modifying sequence for binding second virus; genetic engineered polypeptide |
| 07/04/2006 | US7071172 Secretion signal vectors |
| 07/04/2006 | US7071171 Unique dendritic cell-associated c-type lectins, dectin-1 and dectin-2 compositions and uses thereof |
| 07/04/2006 | US7070998 Supplying Dna to cells; genetic engineering genomes; therapy for central nervous system diosrders |
| 07/04/2006 | US7070995 CE7-specific redirected immune cells |
| 07/04/2006 | US7070994 genetic engineered retrovirus; from transgenic animals; drug transport |
| 07/04/2006 | US7070992 Improved efficiency of gene expression |
| 07/04/2006 | US7070977 Human serine protease D-G polypeptide |
| 07/04/2006 | US7070972 Isolated polynucleotide; catalyst; transformation lymphocytes; antibodies; detecting therapy agents |
| 07/04/2006 | US7070971 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 07/04/2006 | US7070931 Controlling gene expression; calibration |
| 07/04/2006 | US7070807 Administering polypeptide by injection; gene therapy |
| 07/04/2006 | US7070792 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 07/04/2006 | US7070784 Method for down-regulating GDF-8 activity using immunogenic GDF-8 analogues |
| 07/04/2006 | US7070771 Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells |
| 07/04/2006 | US7070759 High dose radionuclide complexes for bone marrow suppression |
| 07/04/2006 | CA2396674C Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
| 07/04/2006 | CA2228956C Cdna corresponding to the antigenome of nonsegmented negative strand rna viruses, and process for the production of such viruses encoding additional antigenically active proteins |
| 06/29/2006 | WO2006069329A2 Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis |
| 06/29/2006 | WO2006069306A2 A knockout mouse for the tumor suppressor gene anx7 |
| 06/29/2006 | WO2006069062A1 Gene therapy vector, localization thereof |
| 06/29/2006 | WO2006069037A1 Rnai inhibition of ctgf for treatment of ocular disorders |
| 06/29/2006 | WO2006068720A2 Hematopoietic cell selectin ligand polypeptides and methods of use thereof |
| 06/29/2006 | WO2006068687A2 Inhibition of hair growth with rnai targeting desmoglein a and nude mrnas |
| 06/29/2006 | WO2006068346A1 Biopolymer and gene complex |
| 06/29/2006 | WO2006068326A1 Novel polypeptide and the use thereof |
| 06/29/2006 | WO2006068232A1 Drug carrier and drug carrier kit for inhibiting fibrosis |
| 06/29/2006 | WO2006067506A2 Hiv resistance genes |